[Estimation of depressant effects of class I antiarrhythmic drugs on intraventricular conduction--rate-dependent effects on QRS duration].
Ikeda
N
N
Cardiology Section, Chunichi Hospital.
Kamiya
K
K
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001073:Aprindine / Q000494:pharmacology; D003864:Depression, Chemical; D004206:Disopyramide / Q000494:pharmacology; D004562:Electrocardiography; D005424:Flecainide / Q000494:pharmacology; D006329:Heart Conduction System / Q000187:drug effects*; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000494:pharmacology; D008801:Mexiletine / Q000494:pharmacology; D015222:Sodium Channels / Q000187:drug effects*; D016276:Ventricular Function
D000889:Anti-Arrhythmia Agents; D015222:Sodium Channels; D008801:Mexiletine; D001073:Aprindine; D008012:Lidocaine; C042288:pilsicainide; D004206:Disopyramide; D005424:Flecainide